Skip to main content
Log in

Lokalablative Therapie beim oligometastasierten nicht-kleinzelligen Bronchialkarzinom

Prospektive klinische Studie zeigt Vorteile

Local ablative therapy of oligometastatic non-small-cell lung cancer

Prospective clinical study shows advantages

  • Journal Club
  • Published:
Der Pneumologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Eberhardt WE, Mitchell A, Crowley J et al (2015) The IASLC lung cancer staging project: Proposals for the revision of the M Descriptors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 10:1515–1522

    Article  PubMed  Google Scholar 

  2. Golden EB, Demaria S, Schiff PB et al (2013) An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res 1:365–372

    Article  PubMed  PubMed Central  Google Scholar 

  3. Gomez DR, Blumenschein GR Jr, Lee JJ et al (2016) Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol 17:1672–1682

    Article  CAS  PubMed  Google Scholar 

  4. Rusthoven KE, Hammerman SF, Kavanagh BD et al (2009) Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis. Acta Oncol 48:578–583

    Article  CAS  PubMed  Google Scholar 

  5. Tönnies S, Tönnies M, Kollmeier J et al (2016) Impact of preoperative 18 F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancer. Lung Cancer 93:28–34

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Walles FETCS.

Ethics declarations

Interessenkonflikt

T. Walles gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

J. Schreiber, Magdeburg

P. Zabel, Lübeck/Borstel

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Walles, T. Lokalablative Therapie beim oligometastasierten nicht-kleinzelligen Bronchialkarzinom. Pneumologe 14, 371–373 (2017). https://doi.org/10.1007/s10405-017-0139-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-017-0139-5

Navigation